| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Gurjit Khurana Hershey, MD-PHD |
A multicenter open-label study |
National Institutes of Health (NIH)/University of Wisconsin-Madison |
UG3OD023282 |
9/1/20-8/31/21 |
$387,085 |
| Gurjit Khurana Hershey, MD-PHD |
P50 SPORE Pilot project #4 Max |
National Institutes of Health (NIH)/University of California San Diego |
UCSanDiego,U19supp |
9/1/20-8/31/21 |
$198,750 |
| Gurjit Khurana Hershey, MD-PHD |
Kinase-independent mechanism o |
National Institutes of Health (NIH) |
1R01AI127392-01A1 |
12/1/21-11/30/22 |
$730,704 |
| Melinda Butsch Kovacic, PHD |
The Neurofibromatosis Clinical |
National Institutes of Health (NIH) |
R25GM129808 |
8/1/21-7/31/22 |
$247,218 |
| Michael Sherenian, MD |
Defining genetic and metabolic |
Amer Acad of Allergy, Asthma & Immunol |
Faculty Development |
7/1/21-6/30/22 |
$80,000 |
| Gurjit Khurana Hershey, MD-PHD |
Targeting MBNL1-mediated alter |
National Institutes of Health (NIH)/Johns Hopkins University |
2004813187 |
3/1/21-2/28/22 |
$798,896 |
| Gurjit Khurana Hershey, MD-PHD |
Targeting Purine Synthesis and |
National Institutes of Health (NIH) |
UAI159087A |
4/1/22-3/31/23 |
$452,000 |
| Tesfaye B Mersha, PHD |
Mechanisms coupling DEK to oncogenesis |
National Institutes of Health (NIH) |
RHG011411A |
9/24/21-6/30/22 |
$680,927 |
| Gurjit Khurana Hershey, MD-PHD |
Strenghening epidermal defense |
National Institutes of Health (NIH) |
2U19AI070235-16 |
9/1/21-6/30/22 |
$1,359,258 |
| Gurjit Khurana Hershey, MD-PHD |
New activities of the human DE |
National Institutes of Health (NIH)/The Board of Regents Univ of Wisconsin |
1464 |
8/1/21-3/31/22 |
$421,349 |
| Gurjit Khurana Hershey, MD-PHD |
FA pathway activities in norma |
National Institutes of Health (NIH)/The Board of Regents Univ of Wisconsin |
1464 |
4/1/22-3/31/23 |
$631,047 |
| Total Annual Grant Award Dollars |
$5,987,234 |
